Fortitude Advisory Group L.L.C. Titan Pharmaceuticals Inc Transaction History

Fortitude Advisory Group L.L.C.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 16, 2022	SELL	$0.38 - $0.94 $3 - $7	-8 Closed	0 $0
Q4 2021 May 20, 2022	BUY	$1.02 - $1.93 $8 - $15	8 New	8 $0

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.